<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Aronowski, Jaroslaw</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Management of Intracerebral Hemorrhage: Looking to the Future</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">The majority of the cell death after hemorrhage occurs around hematomas. It has been theorized that this is partially related to oxidative stress. This article discusses insights from animal models of oxidative stress that may provide potential treatment targets for intracerebral hemorrhage (ICH), hematopoietic stem cell transplantation, and the available neuromonitoring measures and what new measures need to be developed for ICH.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>